1968 Stories, most recent news story added 1 hour 19 minutes ago
Stem cell scientists have modified a human embryonic stem cell (hESC) line to glow red when the stem cells become red blood cells. The modified hESC line, ErythRED, represents a major step forward to the eventual aim of generating mature, fully functional red blood cells from human embryonic stem cells.
LINCOLN -- The NU Board of Regents kept open new possibilities in embryonic stem cell research today, voting 4-4 on a resolution that would have restricted the university's research involving those stem cells.
For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought.Reporting in Oncogene, a publication of Nature Publishing Group, the research teams of Anthony Atala, M.D., director ...
Study anticipated to benefit premature babiesDr. Bernard Thébaud lives in two very different worlds.
OMAHA, Neb. -- The University of Nebraska Board of Regents rejected a resolution Friday that would limit research using stem-cells. The proposal would have required University researchers to abide by rules set during the George W. Bush administration, limiting research to existing stem-cell lines.
Two recent studies investigating the use of human umbilical cord blood stem cell (UCB) transplants for lung and heart disorders in animal models found beneficial results. When human UCB-derived mensenchymal cells were transplanted into newborn laboratory rats with induced oxygen-deprived injury, the effects of the injury lessened. A second study found that UCB mononuclear cells transplanted into ...
Biopharmaceutical company Kiadis Pharma announces today that the first patients have been enrolled in its multinational registration clinical trial with ATIR. The study is designed to show reduction in transplant related mortality after one year following an allogeneic stem cell transplantation with a mismatched donor in blood cancer patients eligible for an allogeneic stem cell transplantation ...
( INSERM (Institut national de la santé et de la recherche médicale) ) Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute, published in the Lancet on Nov. 21, 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells.The goal is to one day be able to ...
ROBBINSVILLE Christmastime last year seemed to bring a stroke of luck to Kevin Scibilia and his family when doctors said they had found a stem cell donor to aid him in his fight against cancer.
CALGARY, ALBERTA--(Marketwire - Nov. 23, 2009) - Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) today announced its financial results for the period ended September 30, 2009. Financial Review The Company's loss for the nine month period ended September 30, 2009 decreased by $957,537 to $3,369,200 ($0.03 per common share) from the loss of $4,326,737 ($0.04 per common ...
By: Courtney Pitts The University of Nebraska’s stem cell research policy stands. ...
As the Senate begins debate this week on a 10 year, $848 billion health care bill, a few lawmakers are positioned to exert enormous influence over President Obama's top priority as the legislation moves toward its final stages.
College student Anna Robinson beat back cancer with the help of an anonymous bone marrow donation. Then she began to wonder: Who was the woman who gifted her with a second chance?
Hard to Treat Diseases and its operating subsidiary Slavica Bio Chem, is providing this brief update to its followers and shareholders. HTDS management continues due diligence with the EU stem cell company and merger discussions.
OCEANSIDE, Calif.----International Stem Cell Corporation , www.internationalstemcell.com announced today that it is collaborating with renowned stem cell researcher Jeanne F. Loring, Ph.D., and the Scripps Research Institute to study parthenogenetic stem cells and potentially therapeutic cells that can be derived from them.
Two opposing sides are staking out their ground in a fight over stem-cell science in South Dakota, with one group now saying it might take its case to the Legislature instead of to voters in an election. South Dakotans for Lifesaving Cures will decide by early December whether to ask lawmakers in January to overturn the state's ban on embryonic stem cell research. "We'll make an announcement ...
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowAFP/Getty Images/File
